COGT
Price
$36.39
Change
-$0.89 (-2.39%)
Updated
Feb 4, 02:32 PM (EDT)
Capitalization
5.73B
41 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$33.09
Change
-$1.14 (-3.33%)
Updated
Feb 4, 02:50 PM (EDT)
Capitalization
3B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs IDYA

Header iconCOGT vs IDYA Comparison
Open Charts COGT vs IDYABanner chart's image
Cogent Biosciences
Price$36.39
Change-$0.89 (-2.39%)
Volume$165
Capitalization5.73B
IDEAYA Biosciences
Price$33.09
Change-$1.14 (-3.33%)
Volume$334
Capitalization3B
COGT vs IDYA Comparison Chart in %
COGT
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COGT vs. IDYA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and IDYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (COGT: $37.28 vs. IDYA: $34.23)
Brand notoriety: COGT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 41% vs. IDYA: 69%
Market capitalization -- COGT: $5.73B vs. IDYA: $3B
COGT [@Biotechnology] is valued at $5.73B. IDYA’s [@Biotechnology] market capitalization is $3B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 6 bearish.
  • IDYA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both COGT and IDYA are a bad buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а -3.19% price change this week, while IDYA (@Biotechnology) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

COGT is expected to report earnings on Mar 17, 2026.

IDYA is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($5.73B) has a higher market cap than IDYA($3B). COGT YTD gains are higher at: 4.955 vs. IDYA (-0.984). IDYA has higher annual earnings (EBITDA): -204.84M vs. COGT (-308.13M). IDYA has more cash in the bank: 787M vs. COGT (391M). IDYA has less debt than COGT: IDYA (27.2M) vs COGT (60.6M). IDYA has higher revenues than COGT: IDYA (215M) vs COGT (0).
COGTIDYACOGT / IDYA
Capitalization5.73B3B191%
EBITDA-308.13M-204.84M150%
Gain YTD4.955-0.984-504%
P/E RatioN/AN/A-
Revenue0215M-
Total Cash391M787M50%
Total Debt60.6M27.2M223%
FUNDAMENTALS RATINGS
COGT vs IDYA: Fundamental Ratings
COGT
IDYA
OUTLOOK RATING
1..100
6967
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
2563
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
3445
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (28) in the null industry is somewhat better than the same rating for COGT (81) in the Miscellaneous industry. This means that IDYA’s stock grew somewhat faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (25) in the Miscellaneous industry is somewhat better than the same rating for IDYA (63) in the null industry. This means that COGT’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as COGT (99) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (34) in the Miscellaneous industry is in the same range as IDYA (45) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as IDYA (100) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIDYA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
IDYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFYCX14.600.16
+1.11%
Hartford Schroders Intl Multi-Cp Val C
VMMSX31.080.24
+0.78%
Vanguard Emerg Mkts Sel Stk Inv
BCREX14.990.07
+0.47%
BlackRock Real Estate Securities Inv C
OAYMX171.31-1.50
-0.87%
Oakmark Advisor
ETCEX12.97-0.32
-2.41%
Eventide Exponential Technologies C

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.79%
SPHDF - COGT
63%
Loosely correlated
N/A
NUVL - COGT
52%
Loosely correlated
+2.12%
IDYA - COGT
50%
Loosely correlated
+0.50%
XNCR - COGT
47%
Loosely correlated
-0.99%
SYRE - COGT
47%
Loosely correlated
+1.65%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.50%
NUVL - IDYA
59%
Loosely correlated
+2.12%
OCUL - IDYA
57%
Loosely correlated
-6.99%
XENE - IDYA
56%
Loosely correlated
+1.62%
XNCR - IDYA
55%
Loosely correlated
-0.99%
BEAM - IDYA
54%
Loosely correlated
-0.11%
More